Cholesterol Supplement can Alleviate the Severity of Pulmonary Infection of Patients with Hypocholesterolemia

Background: Decreased concentrations of total cholesterol concentration could occur in the course of some illness, especially the infection illness. Low cholesterol concentration has been associated clinically with several adverse outcomes. We conducted a study to supplement cholesterol, and observe the change on the test indexes and the severity of disease. We then further discussed the relationships among the supplementation on cholesterol and pro- and anti- inflammatory cytokines. Methods: A randomized and controlled clinical trial was conducted at the infectious disease department in Beijing Friendship Hospital，Capital Medical University，Beijing. Between January 2011 and December 2012, all hospitalized patients with pulmonary infection were invited. The patients were assigned into intervention group and control group randomly. After 10-day supplementation and observation, we analyzed the changes of clinical measurements. Results: In the intervention group, there were statistically significant increases in concentration of total cholesterol (TC), albumin (ALB), pre albumin ( PA) after 10-day intervention of cholesterol supplementation (P 0.05). Compared the differences on indexes between after 10-day intervention in intervention group and after 10-day observation in control group, the compared data showed that there were significant differences in seven indexes, TC, Body Mass Index (BMI), ALB, PA, CRP, IL-6 and the severity of disease (P<0.05). The increased concentrations of TC, ALB and PA in intervention group were more than those changes in control group. The BMI in intervention group was increased more than that in control group. The decreased concentrations of CRP and IL-6 in intervention group were more than those changes in control group. The improvement of severity of disease in intervention group was more obvious than that in control group. The improvement of nutrition status in intervention group was significant. Conclusion: Infectious disease, especially pneumonia and pulmonary infection disease, can lead to hypocholesterolemia. Supplementation of cholesterol properly can improve the nutritional status, decrease the severity of disease, and improve the prognosis of disease.

[1]  Zhi‐hua Liu,et al.  Low plasma total cholesterol concentration:may be related to malnourished hospitalized patients , 2009 .

[2]  Lian-qi Yan.  Relationship between hypocholesterolemia and the prognosis of severe multiple injury , 2007 .

[3]  A. Barros,et al.  Indications and limitations of the use of subjective global assessment in clinical practice: an update , 2006, Current opinion in clinical nutrition and metabolic care.

[4]  Soumitra R. Eachempati,et al.  The relationships of hypocholesterolemia to cytokine concentrations and mortality in critically ill patients with systemic inflammatory response syndrome. , 2004, Surgical infections.

[5]  Xue Hua.  Hypocholesterolemia appears negatively a prognostic parameter , 2004 .

[6]  C. Dunham,et al.  Following severe injury, hypocholesterolemia improves with convalescence but persists with organ failure or onset of infection , 2003, Critical care.

[7]  G. Schmitz,et al.  Apolipoprotein AI and HDL(3) inhibit spreading of primary human monocytes through a mechanism that involves cholesterol depletion and regulation of CDC42. , 2001, Atherosclerosis.

[8]  Z. Varghese,et al.  Dysregulation of LDL receptor under the influence of inflammatory cytokines: a new pathway for foam cell formation. , 2001, Kidney international.

[9]  P. Barie,et al.  Relationship of hypolipidemia to cytokine concentrations and outcomes in critically ill surgical patients , 2001, Critical care medicine.

[10]  P. Connell,et al.  HDL modification by secretory phospholipase A(2) promotes scavenger receptor class B type I interaction and accelerates HDL catabolism. , 2000, Journal of lipid research.

[11]  D. Müller-Wieland,et al.  MAP Kinases Erk1/2 Phosphorylate Sterol Regulatory Element-binding Protein (SREBP)-1a at Serine 117 in Vitro * , 2000, The Journal of Biological Chemistry.

[12]  W. März,et al.  Interleukin-6 stimulates LDL receptor gene expression via activation of sterol-responsive and Sp1 binding elements. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[13]  K. Feingold,et al.  Infection and inflammation induce LDL oxidation in vivo. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[14]  A. Sevanian,et al.  Lipid oxidation products in cell signaling. , 2000, Free radical biology & medicine.

[15]  G. Schmitz,et al.  Lipopolysaccharide inhibits the expression of the scavenger receptor Cla-1 in human monocytes and macrophages. , 1999, Biochemical and biophysical research communications.

[16]  F. Giuliante,et al.  Pathophysiologic correlates of hypocholesterolemia in critically ill surgical patients , 1999, Intensive Care Medicine.

[17]  K. Werdan,et al.  Reduction of Circulating Cholesterol and Apolipoprotein Levels during Sepsis , 1999, Clinical chemistry and laboratory medicine.

[18]  J. Flory,et al.  Immune system differences in men with hypo- or hypercholesterolemia. , 1997, Clinical immunology and immunopathology.

[19]  M. Delgado-Rodríguez,et al.  Total Cholesterol, HDL-Cholesterol, and Risk of Nosocomial Infection: A Prospective Study in Surgical Patients , 1997, Infection Control &#x0026; Hospital Epidemiology.

[20]  P. Barie,et al.  Low lipid concentrations in critical illness: implications for preventing and treating endotoxemia. , 1996, Critical care medicine.

[21]  J. Mosquera,et al.  Variation in Plasma Lipid and Lipoprotein Concentrations in Community-Acquired Pneumonia. A Six-Month Prospective Study , 1996, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

[22]  W. Ettinger,et al.  Cytokines decrease apolipoprotein accumulation in medium from Hep G2 cells. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.